Effect of Bacillus anthracis virulence factors on human dendritic cell activation

Human Immunology

Volumn 69, Issue 9, 2008, Pages 552-561

  Hahn, Andrew C ^a   Lyons, C Rick ^a,b   Lipscomb, Mary F ^a,b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

B. anthracis; B. anthracis capsule; B. anthracis toxins; Human myeloid DC; Human plasmacytoid DC

Indexed keywords

BACTERIAL TOXIN; CYTOKINE; VIRULENCE FACTOR;

ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERIAL STRAIN; BIOSYNTHESIS; BONE MARROW CELL; CELL ACTIVATION; CYTOKINE RELEASE; DENDRITIC CELL; GENETIC ANALYSIS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL;

BACILLUS ANTHRACIS; CYTOKINES; DENDRITIC CELLS; HUMANS; SPORES, BACTERIAL; VIRULENCE FACTORS;

EID: 51749123508     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.06.012     Document Type: Article

References (50)

1. Tournier J.-N., Quesnel-Hellmann A., Cleret A., and Vidal D.R. Contribution of toxins to the pathogenesis of inhalational anthrax. Cell Microbiol 9 (2007) 555
2. Baldari C.T., Tonello F., Paccani S.R., and Montecucco C. Anthrax toxins: A paradigm of bacterial immune suppression. Trends Immunol 27 (2006) 434
3. Mock M., and Fouet A. Anthrax. Annu Rev Microbiol 55 (2001) 647
4. Collier R.J., and Young J.A.T. Anthrax toxin. Annu Rev Cell Dev Biol 19 (2003) 45
5. 2 and a trans-acting element activate transcription from one of two promoters. J Bacteriol 176 (1994) 586
6. Sirard J.C., Mock M., and Fouet A. The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature. J Bacteriol 176 (1994) 5188
7. Dai Z., Sirard J.C., Mock M., and Koehler T.M. The atxA gene product activates transcription of the anthrax toxin genes and is essential for virulence. Mol Microbiol 16 (1995) 1171
8. Uchida I., Hornung J.M., Thorne C.B., Klimpel K.R., and Leppla S.H. Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis. J Bacteriol 175 (1993) 5329
9. Uchida I., Makino S., Sekizaki T., and Terakado N. Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis. Mol Microbiol 23 (1997) 1229
10. Guignot J., Mock M., and Fouet A. AtxA activates the transcription of genes harbored by both Bacillus anthracis virulence plasmids. FEMS Microbiol Lett 147 (1997) 203
11. Drysdale M., Heninger S., Hutt J., Chen Y., Lyons C.R., and Koehler T.M. Capsule Synthesis by Bacillus anthracis is required for issemination in murine inhalation anthrax. EMBO J 24 (2005) 221
12. Schneerson R., Kubler-Kielb J., Liu T.-Y., Dai Z.-D., Leppla S.H., Yergey A., et al. Poly({gamma}-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: A potential addition to the anthrax vaccine. Proc Natl Acad Sci 100 (2003) 8945
13. Makino S.-i., Watarai M., Cheun H.-i., Shirahata T., and Uchida I. Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax. J Infect Dis 186 (2002) 227
14. Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R., Copeland T.D., et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280 (1998) 734
15. Vitale G., Bernardi L., Napolitani G., Mock M., and Montecucco C. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J 352 (2000) 739
16. Vitale G., Pellizzari R., Recchi C., Napolitani G., Mock M., and Montecucco C. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun 248 (1998) 706
17. Pellizzari R., Guidi-Rontani C., Vitale G., Mock M., and Montecucco C. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFN[gamma]-induced release of NO and TNF[alpha]. FEBS Lett 462 (1999) 199
18. Park J.M., Greten F.R., Li Z.-W., and Karin M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297 (2002) 2048
19. Alileche A., Serfass E.R., Muehlbauer S.M., Porcelli S.A., and Brojatsch J. Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response. PLoS Pathogens 1 (2005) e19
20. Dang O., Navarro L., Anderson K., and David M. Cutting edge: Anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide. J Immunol 172 (2004) 747
21. Agrawal A., Lingappa J., Leppla S.H., Agrawal S., Jabbar A., Quinn C., and Pulendran B. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424 (2003) 329
22. Tournier J.-N., Quesnel-Hellmann A., Mathieu J., Montecucco C., Tang W.-J., Mock M., et al. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 174 (2005) 4934
23. Cleret A., Quesnel-Hellmann A., Mathieu J., Vidal D., and Tournier J.-N. Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection. J Infect Dis 194 (2006) 86
24. O'Brien J., Friedlander A., Dreier T., Ezzell J., and Leppla S. Effects of anthrax toxin components on human neutrophils. Infect Immun 47 (1985) 306
25. Hoover D.L., Friedlander A.M., Rogers L.C., Yoon I.K., Warren R.L., and Cross A.S. Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect Immun 62 (1994) 4432
26. Guidi-Rontani C., Weber-Levy M., Labruyere E., and Mock M. Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol 31 (1999) 9
27. Brittingham K.C., Ruthel G., Panchal R.G., Fuller C.L., Ribot W.J., Hoover T.A., et al. Dendritic cells endocytose Bacillus anthracis spores: Implications for anthrax pathogenesis. J Immunol 174 (2005) 5545
28. Dixon T.C., Meselson M., Guillemin J., and Hanna P.C. Anthrax. N Engl J Med 341 (1999) 815
29. Abramova F., Grinberg L., Yampolskaya O., and Walker D. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A 90 (1993) 2291
30. Sansonetti P.J., and Di Santo J.P. Debugging how bacteria manipulate the immune response. Immunity 26 (2007) 149
31. Cleret A., Quesnel-Hellmann A., Vallon-Eberhard A., Verrier B., Jung S., Vidal D., et al. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J Immunol 178 (2007) 7994
32. Pickering A.K., and Merkel T.J. Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores. Infect Immun 72 (2004) 3069
33. Bourgogne A., Drysdale M., Hilsenbeck S.G., Peterson S.N., and Koehler T.M. Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids. Infect Immun 71 (2003) 2736
34. Heninger S., Drysdale M., Lovchik J., Hutt J., Lipscomb M.F., Koehler T.M., and Lyons C.R. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Infect Immun 74 (2006) 6067
35. Stanford M.M., McFadden G., Karupiah G., and Chaudhri G. Immunopathogenesis of poxvirus infections: Forecasting the impending storm. Immunol Cell Biol 85 (2007) 93
36. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179 (1994) 1109
37. Uronen-Hansson H., Steeghs L., Allen J., Dixon G.L.J., Osman M., van der Ley P., et al. Human dendritic cell activation by Neisseria meningitidis: Phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production. Cell Microbiol 6 (2004) 625
38. van der Wel N., Hava D., Houben D., Fluitsma D., van Zon M., Pierson J., et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129 (2007) 1287
39. Shortman K., and Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7 (2007) 19
40. Vermaelen K., and Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med 172 (2005) 530
41. Driks A. Maximum shields: The assembly and function of the bacterial spore coat. Trends Microbiol 10 (2002) 251
42. Glomski I.J., Fritz J.H., Keppler S.J., Balloy V., Chignard M., Mock M., and Goossens P.L. Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell Microbiol 9 (2007) 502
43. Hughes M.A., Green C.S., Lowchyj L., Lee G.M., Grippe V.K., Smith Jr. M.F., Huang L.-Y., Harvill E.T., and Merkel T.J. MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of Mmce: Implications for Toll-like receptor signaling. Infect Immun 73 (2005) 7535
44. Gat O., Grosfeld H., Ariel N., Inbar I., Zaide G., Broder Y., et al. Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen. Infect Immun 74 (2006) 3987
45. Makino S., Uchida I., Terakado N., Sasakawa C., and Yoshikawa M. Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. J Bacteriol 171 (1989) 722
46. Russell B.H., Vasan R., Keene D.R., and Xu Y. Bacillus anthracis internalization by human fibroblasts and epithelial cells. Cell Microbiol 9 (2007) 1262
47. Jarrossay D., Napolitani G., Colonna M., Sallusto F., and Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 31 (2001) 3388
48. Kadowaki N., Ho S., Antonenko S., de Waal Malefyt R., Kastelein R.A., et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J Exp Med 194 (2001) 863
49. Colonna M., Trinchieri G., and Liu Y.-J. Plasmacytoid dendritic cells in immunity. Nat Immunol 5 (2004) 1219
50. Dixon T.C., Fadl A.A., Koehler T.M., Swanson J.A., and Hanna P.C. Early Bacillus anthracis-macrophage interactions: Intracellular survival and escape. Cell Microbiol 2 (2000) 453